Published in Prenat Diagn on May 01, 2010
Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG (2013) 1.51
Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth. BJOG (2015) 1.45
Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab (2013) 0.91
Maternal estriol concentrations in early gestation predict infant telomere length. J Clin Endocrinol Metab (2015) 0.85
Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study. J Perinatol (2015) 0.82
Maternal Serum Screening Markers and Adverse Outcome: A New Perspective. J Clin Med (2014) 0.80
Population-based biomarker screening and the development of severe preeclampsia in California. Am J Obstet Gynecol (2014) 0.77
Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. Int J Med Sci (2017) 0.75
Predictive values of maternal serum PAPP-A level, uterine artery Doppler velocimetry, and fetal biometric measurements for poor pregnancy and poor neonatal outcomes in pregnant women. J Turk Ger Gynecol Assoc (2016) 0.75
Placental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancy. BMC Med Genet (2015) 0.75
Early first trimester peripheral blood cell microRNA predicts risk of preterm delivery in pregnant women: Proof of concept. PLoS One (2017) 0.75
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol (2002) 4.55
The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol (2004) 2.13
Counselling considerations for prenatal genetic screening. J Obstet Gynaecol Can (2012) 2.00
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain (2006) 1.86
Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med (2006) 1.83
Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol (2006) 1.81
Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev Biol (2008) 1.51
A puzzling intrauterine death: non-compaction of the fetal ventricular myocardium presenting with reversed end-diastolic flow velocity in the umbilical arteries. J Obstet Gynaecol Can (2005) 1.51
Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer (2008) 1.45
Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays--an update from the Canadian society of clinical chemists (CSCC). Clin Biochem (2011) 1.41
Genetic education for primary care providers: improving attitudes, knowledge, and confidence. Can Fam Physician (2009) 1.40
Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med (2004) 1.39
Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn (2013) 1.22
Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol (2004) 1.15
Spontaneous dissection of the left main coronary artery. Can J Cardiol (2004) 1.15
Cell specific patterns of methylation in the human placenta. Epigenetics (2011) 1.12
Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations. Genet Med (2009) 1.05
Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab (2007) 1.05
The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol (2010) 1.04
Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can (2013) 1.04
Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol (2011) 1.03
Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review. Int J Pediatr (2010) 1.02
Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol (2006) 1.02
The educational needs and professional roles of Canadian physicians and nurses regarding genetic testing and adult onset hereditary disease. Community Genet (2005) 1.01
Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases. Am J Med Genet A (2008) 0.99
Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol (2013) 0.98
Peroxisome proliferator-activated receptor-γ as a potential therapeutic target in the treatment of preeclampsia. Hypertension (2011) 0.95
Fusion assays and models for the trophoblast. Methods Mol Biol (2008) 0.94
Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol (2003) 0.94
Expectant management compared with elective delivery at 37 weeks for gastroschisis. Obstet Gynecol (2013) 0.93
Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner. Reprod Sci (2009) 0.92
Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics (2011) 0.92
Assessment of the evolution of normal fetal diastolic function during mid and late gestation by spectral Doppler tissue echocardiography. J Am Soc Echocardiogr (2006) 0.92
Value of electrocardiographic and ankle-brachial index abnormalities for prediction of coronary atherosclerosis in asymptomatic subjects with type 2 diabetes mellitus. Am J Cardiol (2007) 0.91
Evidence implicating peroxisome proliferator-activated receptor-γ in the pathogenesis of preeclampsia. Hypertension (2011) 0.91
Male sex bias in placental dysfunction. Am J Med Genet A (2012) 0.90
Interactive genetic counseling role-play: a novel educational strategy for family physicians. J Genet Couns (2008) 0.89
A randomized controlled trial of a bedside partogram in the active management of primiparous labour. J Obstet Gynaecol Can (2007) 0.88
WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate. Epigenetics (2011) 0.87
Perinatal and neurodevelopmental outcome with isolated fetal ventriculomegaly: a systematic review. J Matern Fetal Neonatal Med (2005) 0.87
Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study. BMJ Open (2013) 0.87
Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab (2011) 0.86
Screening of DNA methylation at the H19 promoter or the distal region of its ICR1 ensures efficient detection of chromosome 11p15 epimutations in Russell-Silver syndrome. Am J Med Genet A (2009) 0.86
Glial cell missing-1 mediates over-expression of tissue inhibitor of metalloproteinase-4 in severe pre-eclamptic placental villi. Hum Reprod (2011) 0.86
Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F 2 alpha. Reprod Sci (2010) 0.85
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev (2010) 0.85
Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy (2005) 0.83
Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro. Anesthesiology (2013) 0.83
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev (2013) 0.82
Elective non-removal of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: a case report. J Obstet Gynaecol Can (2004) 0.82
Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynaecol Can (2002) 0.81
Complex umbilical cord entanglement. J Matern Fetal Neonatal Med (2012) 0.81
Maternal cell contamination of amniotic fluid samples obtained by open needle versus trocar technique of amniocentesis. J Obstet Gynaecol Can (2002) 0.81
The impact of maternal weight discrepancies on prenatal screening results for Down syndrome. Prenat Diagn (2013) 0.81
A new era in prenatal diagnosis: the use of cell-free fetal DNA in maternal circulation for detection of chromosomal aneuploidies. Clin Chem (2013) 0.80
Angiogenic response of placental villi to heparin. Obstet Gynecol (2011) 0.80
Rounded intraplacental haematomas due to decidual vasculopathy have a distinctive morphology. J Clin Pathol (2011) 0.80
Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center. Prenat Diagn (2008) 0.79
Non-invasive hemodynamic assessment of non-pregnant, healthy pregnant and preeclamptic women using bioreactance. [corrected]. Rev Bras Anestesiol (2010) 0.79
Complications of exteriorized compared with in situ uterine repair at cesarean delivery under spinal anesthesia: a randomized controlled trial. Obstet Gynecol (2007) 0.78
Third-trimester stillbirths: correlative neuropathology and placental pathology. Pediatr Dev Pathol (2011) 0.78
The management of VBAC at term: a survey of Canadian obstetricians. J Obstet Gynaecol Can (2003) 0.78
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thromb Haemost (2007) 0.78
The Effect of Extracellular Calcium on Oxytocin-Induced Contractility in Naive and Oxytocin-Pretreated Human Myometrium In Vitro. Anesth Analg (2016) 0.78
Genetic considerations for a woman's pre-conception evaluation. J Obstet Gynaecol Can (2011) 0.77
Angiogenic factor abnormalities and fetal demise in a twin pregnancy. Nat Rev Nephrol (2009) 0.77
Prenatal diagnosis, clinical outcomes, and associated pathology in pregnancies complicated by massive subchorionic thrombohematoma (Breus' mole). Prenat Diagn (2013) 0.77
Treatment options in fetomaternal hemorrhage: four case studies. J Obstet Gynaecol Can (2004) 0.76
Basal plate plaque: a novel organising placental thrombotic process. J Clin Pathol (2011) 0.75
Nonpresenting Dichorionic Twins and Placental Vascular Malperfusion. Obstet Gynecol (2017) 0.75
The Contractile Effects of Oxytocin, Ergonovine, and Carboprost and Their Combinations: an In Vitro Study on Human Myometrial Strips. Anesth Analg (2015) 0.75
Spontaneous uterine rupture. J Obstet Gynaecol Can (2009) 0.75
Middle and inner ear malformations in mutation-proven branchio-oculo-facial (BOF) syndrome: case series and review of the literature. Am J Med Genet A (2012) 0.75
Comparative efficacy of uterotonic agents: in vitro contractions in isolated myometrial strips of labouring and non-labouring women. Can J Anaesth (2014) 0.75
Altered placental development in pregnancies resulting in sudden infant death syndrome (SIDS). Early Hum Dev (2012) 0.75
Toronto's Mount Sinai Hospital offers first-trimester screening across Ontario. Healthc Q (2004) 0.75
Contractile efficacy of various prostaglandins in pregnant rat myometrium pretreated with oxytocin. Reprod Sci (2012) 0.75
Misoprostol associated refractile material in fetal and placental tissues after medical termination of pregnancy. Am J Surg Pathol (2007) 0.75
Maternal Vascular Malperfusion and Adverse Perinatal Outcomes in Low-Risk Nulliparous Women. Obstet Gynecol (2017) 0.75